- Feb 12, 2007
- 59,384
- 24,019
- 2,290
- Thread starter
- #121
The FDA did not look at cost. It looked at effectiveness.
The Federal Health Officials who are pushing for revocation of the approval are very likely looking at costs.
That's what HHS will largely be doing for ObamaCare. Deciding which procedures and drugs cost are not cost effective (based on how the government values one's life) is their raison d'etre.
you learned nothing in this thread.
well done.
As if I give a fig what a moron like you thinks.
You've learned nothing over the past two years, and likely during a much more extensive period prior to that.